NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page

Neuro-Bio’s CEO debate at the House of Lords.

On Tuesday the 17th of May, Neuro-Bio’s CEO, Baroness Susan Greenfield, had a debate at the House of Lords, in London. The principal topics for the debate will be education, welfare, health and public services, therefore Susan Greenfield will be talking about the Alzheimer’s’ disease. Watch the video below for the full speech.

https://neuro-bio.com/wp-content/uploads/2022/05/House_of_Lords_17-05-22_19-10-00-1_Trim_Trim.mp4

 

LATEST NEWS

  • Neuro-Bio’s first paper of 2026 has been published!
  • Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
  • CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
  • Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!

TOPICS

  • Latest News
  • Media

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025